INTERNATIONAL PATENT: TARGIMMUNE THERAPEUTICS AG FILES APPLICATION FOR "POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL"

GENEVA, Nov. 24 -- TARGIMMUNE THERAPEUTICS AG (Hochbergerstrasse 60c4057 Basel) filed a patent application (PCT/EP2025/063599) for "POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL" on May 16, 2025. With publication no. WO/2025/238236, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZIGLER, Maya (Hirzbodenweg 174052 Basel), SHIR, Alexei (7/7 Shmuel Tamir Street9781207 Jerusalem), KITAS, Eric (Eichbergweg 44147 Aesch), POMBO-VILLAR, Esteban (Hohenweg 634102 Binningen)...